1006281 |
|
Protalix BioTherapeutics, Inc. |
0001104659-23-062301 |
2023-05-18 17:00:17 |
DEF 14A
|
1006281 |
|
Protalix BioTherapeutics, Inc. |
0001140361-22-022449 |
2022-06-09 14:52:54 |
SC 13G
|
1006281 |
|
Protalix BioTherapeutics, Inc. |
0001104659-22-053664 |
2022-04-29 16:36:58 |
DEF 14A
|
1006281 |
|
Protalix BioTherapeutics, Inc. |
0001558370-21-012901 |
2021-09-30 16:30:44 |
DEF 14A
|
1006281 |
|
Protalix BioTherapeutics, Inc. |
0001558370-21-008019 |
2021-06-04 16:30:47 |
DEF 14A
|
1006281 |
|
Protalix BioTherapeutics, Inc. |
0001437749-21-002709 |
2021-02-12 12:00:18 |
SC 13G
|
1006281 |
|
Protalix BioTherapeutics, Inc. |
0001178913-20-003242 |
2020-11-24 06:04:41 |
SC 13G
|
1006281 |
|
Protalix BioTherapeutics, Inc. |
0001104659-20-046926 |
2020-04-15 16:30:15 |
DEF 14A
|
1006281 |
|
Protalix BioTherapeutics, Inc. |
0001213900-20-007898 |
2020-03-30 14:12:47 |
SC 13G
|
1006281 |
|
Protalix BioTherapeutics, Inc. |
0001104659-20-038290 |
2020-03-25 16:16:05 |
SC 13G
|
1006281 |
|
Protalix BioTherapeutics, Inc. |
0000902664-20-001614 |
2020-03-23 16:05:33 |
SC 13G
|
1006281 |
|
Protalix BioTherapeutics, Inc. |
0001104659-19-054172 |
2019-10-15 16:30:25 |
DEF 14A
|
1006281 |
|
Protalix BioTherapeutics, Inc. |
0001144204-19-019545 |
2019-04-12 17:00:30 |
DEF 14A
|
1006281 |
|
Protalix BioTherapeutics, Inc. |
0001144204-18-054229 |
2018-10-17 16:31:03 |
DEF 14A
|
1006281 |
|
Protalix BioTherapeutics, Inc. |
0001571049-18-000157 |
2018-03-06 16:11:37 |
DEF 14A
|
1006281 |
|
Protalix BioTherapeutics, Inc. |
0001140361-18-006088 |
2018-02-09 13:17:05 |
SC 13G
|
1006281 |
|
Protalix BioTherapeutics, Inc. |
0001144204-17-046387 |
2017-09-01 16:04:24 |
DEF 14A
|
1006281 |
|
Protalix BioTherapeutics, Inc. |
0001144204-17-045196 |
2017-08-25 16:30:13 |
DEF 14A
|
1006281 |
|
Protalix BioTherapeutics, Inc. |
0001144204-17-015102 |
2017-03-16 16:21:12 |
DEF 14A
|
1006281 |
|
Protalix BioTherapeutics, Inc. |
0001193125-17-044862 |
2017-02-15 12:20:02 |
SC 13G
|
1006281 |
|
Protalix BioTherapeutics, Inc. |
0001193125-17-043819 |
2017-02-14 17:37:19 |
SC 13G
|
1006281 |
|
Protalix BioTherapeutics, Inc. |
0001019056-17-000090 |
2017-02-01 17:01:37 |
SC 13G
|
1006281 |
|
Protalix BioTherapeutics, Inc. |
0000902664-16-009187 |
2016-12-23 16:15:34 |
SC 13G
|
1006281 |
|
Protalix BioTherapeutics, Inc. |
0001144204-16-111273 |
2016-07-01 17:04:30 |
DEF 14A
|
1006281 |
|
Protalix BioTherapeutics, Inc. |
0001546927-15-000285 |
2015-11-23 16:48:58 |
SC 13G
|
1006281 |
|
Protalix BioTherapeutics, Inc. |
0000078003-15-000046 |
2015-10-23 15:46:24 |
SC 13G
|
1006281 |
|
Protalix BioTherapeutics, Inc. |
0001178913-15-003115 |
2015-10-22 09:25:44 |
SC 13G
|
1006281 |
|
Protalix BioTherapeutics, Inc. |
0001144204-15-057696 |
2015-10-01 16:30:50 |
DEF 14A
|
1006281 |
|
Protalix BioTherapeutics, Inc. |
0001178913-15-001990 |
2015-06-09 12:05:15 |
SC 13G
|
1006281 |
|
Protalix BioTherapeutics, Inc. |
0001178913-15-001281 |
2015-04-21 06:05:13 |
SC 13G
|
1006281 |
|
Protalix BioTherapeutics, Inc. |
0001546927-15-000122 |
2015-04-20 16:37:22 |
SC 13G
|
1006281 |
|
Protalix BioTherapeutics, Inc. |
0001085146-15-000613 |
2015-02-17 08:23:42 |
SC 13G
|
1006281 |
|
Protalix BioTherapeutics, Inc. |
0001144204-14-060401 |
2014-10-09 16:30:27 |
DEF 14A
|
1006281 |
|
Protalix BioTherapeutics, Inc. |
0001445305-14-000397 |
2014-02-12 14:25:07 |
SC 13G
|
1006281 |
|
Protalix BioTherapeutics, Inc. |
0001088875-14-000020 |
2014-01-28 09:57:55 |
SC 13G
|
1006281 |
|
Protalix BioTherapeutics, Inc. |
0001144204-13-051645 |
2013-09-19 19:04:48 |
DEF 14A
|
1006281 |
|
Protalix BioTherapeutics, Inc. |
0001144204-12-030772 |
2012-05-21 08:12:03 |
DEF 14A
|
1006281 |
|
Protalix BioTherapeutics, Inc. |
0001318148-12-000229 |
2012-02-09 09:32:51 |
SC 13G
|
1006281 |
|
Protalix BioTherapeutics, Inc. |
0001144204-11-053749 |
2011-09-19 16:42:42 |
DEF 14A
|
1006281 |
|
Protalix BioTherapeutics, Inc. |
0001088875-11-000006 |
2011-01-25 11:29:08 |
SC 13G
|
1006281 |
|
Protalix BioTherapeutics, Inc. |
0000950123-10-091152 |
2010-10-04 16:46:35 |
DEF 14A
|
1006281 |
|
Protalix BioTherapeutics, Inc. |
0000315066-10-002033 |
2010-02-16 12:56:02 |
SC 13G
|
1006281 |
|
Protalix BioTherapeutics, Inc. |
0001178913-09-002263 |
2009-09-24 11:00:46 |
SC 13G
|
1006281 |
|
Protalix BioTherapeutics, Inc. |
0000950123-09-043950 |
2009-09-17 19:47:03 |
DEF 14A
|
1006281 |
|
Protalix BioTherapeutics, Inc. |
0001178913-08-002725 |
2008-10-29 10:19:29 |
SC 13D
|
1006281 |
|
Protalix BioTherapeutics, Inc. |
0000950123-08-012018 |
2008-10-03 17:21:15 |
DEF 14A
|
1006281 |
|
Protalix BioTherapeutics, Inc. |
0000950123-08-008431 |
2008-07-29 09:09:26 |
SC 13D
|
1006281 |
|
Protalix BioTherapeutics, Inc. |
0000950136-07-008573 |
2007-12-31 10:26:54 |
DEF 14A
|
1006281 |
|
Protalix BioTherapeutics, Inc. |
0001193125-05-239732 |
2005-12-09 12:01:40 |
SC 13D
|
1006281 |
|
Protalix BioTherapeutics, Inc. |
0000950170-99-001401 |
1999-09-03 00:00:00 |
SC 13D
|